Skip to main content
E. David Crawford, MD, Urology, San Diego, CA

E. DavidCrawfordMD

Urology San Diego, CA

Surgical Oncology, Clinical Informatics

Professor of Urology, Department of Urology, University of California San Diego , CA

Dr. Crawford is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Crawford's full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 720-848-0000
    Fax+1 888-539-8781

Summary

  • I am a board-certified urologist who has devoted my career in medicine to educating the public about men's health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.
    I am an internationally recognized expert in benign prostate hypertrophy, urologic cancers, and in particular, prostate cancer.
    As a professor in the Department of Urology, I instruct medical students, residents and fellows at UC San Diego School of Medicine. I have conducted research in the treatment of advanced bladder cancer, metastatic adenocarcinoma of the prostate, hormone refractory prostate cancer, and other areas of urological infections and malignancies. I have authored or coauthored over 810 scientific articles, published seven textbooks, authored over 60 book chapters and provided more than 2,200 educational talks for patients and physicians. I serve as editor in chief of Grand Rounds in Urology since June of 2019.
    In an effort to raise public awareness about prostate health, Ifounded the Prostate Conditions Education Council (PCEC) in 1989. The non-profit organization is comprised of a consortium of leading physicians, health educators, scientists and men's health advocates. PCEC's advocacy for free or low-cost prostate screening has affected the lives of millions of American men. I currently chair the PCEC.

    Consistently recognized as one of the Best Doctors of America for the past two decades, I was ranked as one of the top 20 urologists in the country by Men’s Health Magazine. In May of 2019, I received the presidential citation from the American Urological Association in recognition of his “tireless role in genitourinary cancer research that has benefited countless urologic cancer patients

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1977 - 1978
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Urology, 1974 - 1977
  • TriHealth (Bethesda North Hospital)
    TriHealth (Bethesda North Hospital)Internship, Transitional Year, 1973 - 1974
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • CO State Medical License
    CO State Medical License 1986 - 2025
  • FL State Medical License
    FL State Medical License 2012 - 2016
  • NM State Medical License
    NM State Medical License 1978 - 1994
  • OH State Medical License
    OH State Medical License 1974 - 1986
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2013, 2018
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Prostate Cancer Test from Genomic Health Assesses Risks [NY Times]
    Prostate Cancer Test from Genomic Health Assesses Risks [NY Times]May 8th, 2013
  • Precision Biopsy Names CEO, Announces Clinical-Trial Success
    Precision Biopsy Names CEO, Announces Clinical-Trial SuccessFebruary 11th, 2013
  • FDA Approves Medivation Prostate Cancer Drug
    FDA Approves Medivation Prostate Cancer DrugAugust 31st, 2012
  • Join now to see all

Professional Memberships